Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. Januar 2017 16:11 ET | Quelle: Agile Therapeutics, Inc.

Agile Therapeutics Announces Positive Top-line Phase 3 Results

Resubmission of Twirla® New Drug Application Expected to Address FDA’s Complete Response LetterCompany Plans to Resubmit NDA in First Half of...
09. Mai 2016 16:10 ET | Quelle: Agile Therapeutics, Inc.

Agile Therapeutics Reports First Quarter 2016 Financial Results

Cash Expected to Fund Operations through the End of 2017Clinical Trial Expected to Complete in Fourth Quarter 2016 and Resubmission Planned for First Half 2017 PRINCETON, N.J., May 09, 2016 ...
24. Februar 2016 16:15 ET | Quelle: Agile Therapeutics, Inc.

Agile Therapeutics Appoints Ajit S. Shetty, Ph.D., to Its Board of Directors

PRINCETON, N.J., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) today announced that Ajit S. Shetty, Ph.D., has been appointed to the Company's Board of Directors,...